Avid Bioservices Inc (CDMO): That was my first thought ( thinking the...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	86
Posts	12714
Boards Moderated	0
Alias Born	10/12/2010

biopharm

Re: stoneroad post# 274071

Saturday, 10/01/2016 5:49:56 AM

Saturday, October 01, 2016 5:49:56 AM

That was my first thought ( thinking the biomarker could have been simply FLIPPED PS) but details upon detail required it seems now, especially since all can see deeper within the cell at all the proteins...

I am still curious how much is revealed because I doubt Peregrine wants to reveal too much and not risk someone reverse engineering their drug??

Hopefully they patent away and I have no idea how it would be possible for someone to patent the same ...."all" the same pathways that change to protein levels ...etc Since Peregrine are the only ones that can target flipped PS

Looking forward to Oct 10 and Wolchok and others ... The door is wide open and all must realize now that all of Big Pharma will not ....NOT all agree that the time for Bavi is not now

PS Targeting increases responders....allows adaptive immunity....and ready to go

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!